Please login to read the full article.
Scrip Regulatory Affairs
Quality by Design - a status report
01 June 2011
Siegfried Schmitt
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- FDA report questions whether US rules can ensure quality of marketed medical devices
- Brand vs generic: the battle rages over EU anti-counterfeit 'safety features'
- EMA policy on allowing access to EudraVigilance data imminent
- GHTF proposes risk-based approach to rate non-conformities in device QMS audits
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
